SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-236397
Filing Date
2020-08-31
Accepted
2020-08-31 17:23:09
Documents
12
Period of Report
2020-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d91302d8k.htm   iXBRL 8-K 23490
  Complete submission text file 0001193125-20-236397.txt   146067

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ubx-20200828.xsd EX-101.SCH 3083
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20200828_lab.xml EX-101.LAB 18121
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20200828_pre.xml EX-101.PRE 11414
5 EXTRACTED XBRL INSTANCE DOCUMENT d91302d8k_htm.xml XML 3363
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 201152599
SIC: 2834 Pharmaceutical Preparations